Moderna says infant Covid vaccine succeeded in trial

WASHINGTON: US biotech firm Moderna on Wednesday said it was pursuing regulatory approval for its Covid vaccine in children under six years old after the two-shot regimen was found to be safe and produced a strong immune response.